BackSyros Pharmaceuticals Overview

Syros Pharmaceuticals Selling, General & Admin

Selling, General & Admin expenses for SYRS.

Quarterly SG&A Expenses

$5.66M
↓ 27.16% YoY

As of Sep 30, 2024

Annual SG&A Expenses (TTM)

$23.27M
↓ 21.7% YoY

Trailing 12 months ending Sep 30, 2024

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin